RxDoctor Payments Data

Sarah Gutierrez, PA

Medical · Reno, NVNPI 1528495173

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 95.1% of the total across 352 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 22 manufacturers reported payments, led by AbbVie at 25.2% of the total. 2025 is the largest year on record at $2,197, 7.6 times the $289 reported in 2021.

$6,370in general payments, 2019–2025

Across 352 payments — averaging $18.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Johnson & Johnson$1K
  • Lilly USA, LLC$679
  • Sun Pharmaceutical Industries Inc.$668
  • Sanofi$419
  • Novartis$324
  • plus $2K from 16 others

What the payments were for

  • Food & beverage$6,05695%
  • Education$3155%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,370 in reported general payments places this provider in the 85th percentile of 250 medical providers in Nevada.

See all medical providers in Nevada

Medicare billing

Part B allowed, 2024
$147,216
Medicare patients
563
Services billed
3,605

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ivermectin11$4,269
Fluorouracil58$3,131
Calcipotriene21$2,057
Clobetasol Propionate66$1,736
Ketoconazole100$1,665
Metronidazole36$1,197
Triamcinolone Acetonide101$1,094
Fluocinolone Acetonide28$1,059
Doxycycline Monohydrate31$977
Tacrolimus12$535
Finasteride29$395
ValacyclovirValacyclovir Hcl15$356
Clindamycin Phosphate11$278
Mupirocin18$135
Hydrocortisone16$86

Paid to pharmacies, not to this prescriber.

Other medical in Reno

See the full list for Nevada

Where these figures come from

Is this you, or does something look wrong? →